|
TDP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.102200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.859600E-01 |
| Normal-vs-Stage2 |
8.196400E-01 |
| Normal-vs-Stage3 |
6.621600E-01 |
| Normal-vs-Stage4 |
3.489800E-01 |
| Stage1-vs-Stage2 |
9.092000E-01 |
| Stage1-vs-Stage3 |
7.639000E-01 |
| Stage1-vs-Stage4 |
3.695800E-01 |
| Stage2-vs-Stage3 |
9.172800E-01 |
| Stage2-vs-Stage4 |
3.800200E-01 |
| Stage3-vs-Stage4 |
3.363000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.312400E-01 |
| Normal-vs-AfricanAmerican |
6.418400E-01 |
| Normal-vs-Asian |
3.444600E-01 |
| Caucasian-vs-AfricanAmerican |
9.017400E-01 |
| Caucasian-vs-Asian |
5.644000E-01 |
| AfricanAmerican-vs-Asian |
6.354600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.113600E-01 |
| Normal-vs-Female |
1.257820E-01 |
| Male-vs-Female |
8.120300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.304400E-01 |
| Normal-vs-Extreme_Weight |
7.330000E-01 |
| Normal-vs-Obese |
2.661400E-01 |
| Normal-vs-Extreme_Obese |
6.267800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.133000E-01 |
| Normal_Weight-vs-Obese |
1.108380E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.692600E-01 |
| Extreme_Weight-vs-Obese |
1.008580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.925600E-01 |
| Obese-vs-Extreme_Obese |
3.332800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.606400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.431400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.537800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.826100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.917400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.454100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.736180E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.879990E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.180300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.537790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.208000E-01 |
| Normal-VS-Type2 PRCC |
2.776000E-01 |
| Normal-VS-KIRP CIMP |
4.563600E-01 |
| Normal-VS-Unclassified PRCC |
3.281800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.238410E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.328400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.779400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.352780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.204500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.908400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.176600E-01 |
| Normal-vs-N1 |
1.937810E-01 |
| Normal-vs-N2 |
2.746100E-02 |
| N0-vs-N1 |
3.118300E-02 |
| N0-vs-N2 |
1.054800E-01 |
| N1-vs-N2 |
3.849800E-02 |
|
|
